II CARE

Indications

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Hypertension
• Heart Failure
• Cardiac Arrhythmias

Dosage

Children: Refer to the BNF for Children for appropriate dosing

Adults: Refer to the BNF for specific dosing guidelines based on the condition being treated and the formulation of the drug used.

Mechanism of action

Beta-adrenergic agonists stimulate beta-adrenergic receptors, leading to increased intracellular cAMP levels, which causes relaxation of bronchial smooth muscle and dilation of the airways. This mechanism is particularly important in the treatment of asthma and COPD, where airway constriction is a major issue. Beta-blockers, on the other hand, inhibit the effects of catecholamines on beta receptors, resulting in decreased heart rate and myocardial contractility, which is beneficial in managing hypertension and certain types of cardiac arrhythmias.

Pharmacodynamics

The pharmacodynamics of beta drugs vary depending on whether they are agonists or antagonists. Agonists lead to a dose-dependent bronchodilation and increased heart rate, while antagonists decrease heart rate and myocardial oxygen demand. The effects of these drugs can be influenced by patient-specific factors such as receptor sensitivity, presence of comorbid conditions, and concurrent medications.

Pharmacokinetics

The pharmacokinetics of beta drugs can differ substantially. Agonists are typically rapidly absorbed and distributed, with onset of action occurring within minutes. They may have short half-lives, necessitating multiple doses throughout the day. Beta-blockers, in contrast, may have longer half-lives and can be administered once or twice daily. Metabolism usually occurs in the liver, and renal excretion is common for both classes, affecting their dosing in patients with renal impairment.

Interactions

• betablockers, selective + aminophylline: Severe (increases risk of bronchospasm)
• dacomitinib + betablockers, selective: Severe (increases exposure)
• mexiletine + betablockers, selective: Severe (increases risk of cardiovascular adverse effects)
• betablockers, selective + theophylline: Severe (increases risk of bronchospasm)
• beta 2 agonists + linezolid: Severe (increases risk of elevated blood pressure)
• mao-b inhibitors + beta: Severe (increases risk of severe hypertension)
• verapamil + betablockers, non-selective: Severe (increases risk of cardiovascular adverse effects)
• cobicistat + beta: Severe (increases exposure)
• dacomitinib + betablockers, non-selective: Severe (increases exposure)
• idelalisib + beta: Severe (increases exposure)

Indications

• Improvement of visual function
• Support for eye health
• Management of diabetic retinopathy
• Enhancement of microcirculation
• Support for cardiovascular health

Dosage

Children: Consult a healthcare provider for appropriate dosing in children, as specific pediatric dosing may not be established.

Adults: Refer to specific product guidelines or consult a healthcare provider for dosing information, as it can vary based on formulation.

Mechanism of action

Bilberry is thought to exert its effects primarily through the action of anthocyanins, which have been shown to improve visual function and circulation. These compounds may enhance the integrity of the vascular system, inhibit oxidative stress, and improve microcirculation, particularly in the retina, thus potentially aiding in conditions like night blindness and age-related macular degeneration.

Pharmacodynamics

The pharmacodynamic effects of bilberry are largely attributed to its antioxidant properties, which help to scavenge free radicals and reduce oxidative damage in tissues. The anthocyanins in bilberry may also modulate inflammatory responses and improve endothelial function, contributing to better blood flow and reduced risk of cardiovascular complications.

Pharmacokinetics

Bilberry extracts are typically administered orally, and the active constituents are absorbed in the gastrointestinal tract. The bioavailability of anthocyanins can be influenced by factors such as food intake and gastrointestinal pH. Once absorbed, these compounds are metabolized in the liver and excreted primarily through urine. The half-life of bilberry components varies and is influenced by the specific anthocyanins and the formulation used.

Adverse effects

• Gastrointestinal upset
• Allergic reactions
• Headache
• Dizziness

Interactions

• Anticoagulants
• Antiplatelet drugs
• Diabetes medications

Precautions

• Use with caution in individuals with bleeding disorders
• Caution in patients undergoing surgery due to potential bleeding effects

Pregnancy

Bilberry is classified as safe for use during pregnancy, but it should be used under the guidance of a healthcare provider.

Breast-feeding

There is insufficient reliable information regarding the safety of bilberry during breastfeeding, thus caution is advised.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Dried berries
• Powdered extract
• Capsules
• Liquid extract

Indications

• Vitamin A deficiency
• Supplementation for eye health
• Antioxidant support

Dosage

Children: Refer to the BNF for Children for specific dosage recommendations, as they may vary based on the clinical indication and individual patient factors.

Adults: Refer to the BNF for specific dosage recommendations, as they may vary based on the clinical indication and individual patient factors.

Mechanism of action

Carotene acts primarily as a provitamin A, which means it can be converted into retinol (vitamin A) in the body. This conversion occurs in the intestinal mucosa and liver, where carotene is cleaved by the enzyme beta-carotene 15,15'-monooxygenase. The resulting retinol is essential for various biological functions, including the maintenance of vision, epithelial integrity, and reproductive health. Additionally, carotene possesses antioxidant properties, helping to neutralize free radicals and reduce oxidative stress.

Pharmacodynamics

Carotene exhibits its effects through its conversion to vitamin A, which is vital for the maintenance of normal vision, immune function, and cellular health. As an antioxidant, carotene helps protect the body from oxidative stress, which can contribute to chronic diseases such as cancer and cardiovascular disease.

Pharmacokinetics

Carotene is absorbed in the intestine, particularly in the presence of dietary fats, as it is a fat-soluble compound. Once absorbed, it is transported in the bloodstream by lipoproteins and stored in the liver and adipose tissues. The bioavailability of carotene can be influenced by dietary factors, such as the presence of fat and the matrix of the food source. The half-life and metabolism of carotene can vary significantly based on individual factors, including genetics and dietary habits.

Pregnancy

Carotene is generally considered safe during pregnancy, but high doses should be avoided as they may pose risks.

Breast-feeding

Carotene is excreted in breast milk in small amounts and is not known to cause harm to nursing infants.

Storage

Store in a cool, dry place, protected from light.

Formulations

• Capsules
• Tablets
• Liquid preparations

Indications

• General wellness support
• Anti-inflammatory effects
• Antioxidant activity
• Digestive aid
• Support for immune function

Dosage

Children: Paediatric dosing should be determined based on the specific extract and its intended use. Consultation with a healthcare provider is recommended for accurate dosing.

Adults: Dosage varies widely depending on the specific extract and formulation. It is essential to follow the manufacturer's instructions or consult a healthcare professional for appropriate dosing.

Mechanism of action

The mechanism of action of herbal extracts can vary significantly based on their constituents. Commonly, they exert their effects through multiple pathways including modulation of neurotransmitter systems, interference with inflammatory processes, or direct antioxidant activity. Some extracts may activate certain receptors or inhibit enzymes related to disease processes.

Pharmacodynamics

The pharmacodynamics of extracts is complex due to the presence of multiple active compounds which can have synergistic or antagonistic effects. These compounds may influence cellular signaling pathways, alter gene expression, or modulate immune response. The overall pharmacological profile is determined by the specific composition of the extract, its concentration, and the biological target it interacts with.

Pharmacokinetics

The pharmacokinetics of extracts involves absorption, distribution, metabolism, and excretion of the active compounds. Generally, herbal extracts are absorbed in the gastrointestinal tract, with bioavailability influenced by factors such as formulation, the presence of food, and individual metabolic differences. Compounds may undergo hepatic metabolism, and elimination can occur through urine or feces, depending on their chemical nature.

Pregnancy

Consult a healthcare professional before use, as the safety of the extract during pregnancy has not been established.

Breast-feeding

Consult a healthcare professional before use, as the safety of the extract during breastfeeding has not been established.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Age-related Macular Degeneration (AMD)
• Cataracts
• Ocular health protection
• Antioxidant support

Dosage

Children: Refer to BNF for Children for specific dosage guidance as it may vary based on formulation and clinical indication.

Adults: Refer to BNF for specific dosage guidance as it may vary based on formulation and clinical indication.

Mechanism of action

Lutein exhibits antioxidant activity by reacting with active oxygen species, leading to the production of biologically active degradation products. It inhibits the peroxidation of membrane phospholipids and reduces lipofuscin formation, which are key contributors to oxidative stress. Additionally, lutein filters blue light and near-ultraviolet radiation, providing protective effects in the retina due to its ability to scavenge reactive oxygen species. It also enhances the expression of connexin-43, facilitating gap junctional communication and offering potential protection against cancer.

Pharmacodynamics

Lutein is concentrated in the macula of the retina, where it exerts protective effects against oxidative stress and high-energy light. Its presence is linked to a decreased risk of developing eye diseases such as Age-related Macular Degeneration (AMD). Studies indicate that higher macular pigment density is associated with a reduced risk of these conditions, highlighting lutein's role in maintaining eye health.

Pharmacokinetics

Lutein is absorbed in the gastrointestinal tract and its bioavailability can be influenced by the presence of dietary fats. It is transported in the bloodstream primarily via lipoproteins and is distributed to various tissues, with a significant accumulation in the retina and lenses of the eyes. The elimination half-life and metabolic pathways are not well characterized, but lutein is known to be more stable against degradation by pro-oxidants compared to other carotenoids.

Pregnancy

Lutein is generally considered safe during pregnancy, but consult a healthcare provider for individual assessment.

Breast-feeding

Lutein is likely safe during breastfeeding, but it is advisable to consult a healthcare provider.

Storage

Store in a cool, dry place away from light.

Formulations

• Supplement capsules
• Softgel formulations
• Powdered forms for mixing

Mechanism of action

Xanthophylls have antioxidant activity and react with active oxygen species, producing biologically active degradation products. They also can inhibit peroxidation of membrane phospholipids and reduce lipofuscin formation, both of which contribute to their antioxidant properties. Lutein is naturally present in the macula of the human retina. It filters out potentially phototoxic blue light and near-ultraviolet radiation from the macula. The protective effect is due in part, to the reactive oxygen species quenching ability of these carotenoids. Lutein is more stable to decomposition by pro-oxidants than are other carotenoids such as beta-carotene and lycopene. Lutein is abundant in the region surrounding the fovea, and lutein is the predominant pigment at the outermost periphery of the macula. Zeaxanthin, which is fully conjugated (lutein is not), may offer somewhat better protection than lutein against phototoxic damage caused by blue and near-ultraviolet light radiation. Lutein is one of only two carotenoids that have been identified in the human lens, may be protective against age-related increases in lens density and cataract formation. Again, the possible protection afforded by lutein may be accounted for, in part, by its reactive oxygen species scavenging abilities. Carotenoids also provide protection from cancer. One of the mechanisms of this is by increasing the expression of the protein connexin-43, thereby stimulating gap junctional communication and preventing unrestrained cell proliferation.

Pharmacodynamics

Lutein was found to be present in a concentrated area of the macula, a small area of the retina responsible for central vision. The hypothesis for the natural concentration is that lutein helps protect from oxidative stress and high-energy light. Several studies show that an increase in macula pigmentation decreases the risk for eye diseases such as Age-related Macular Degeneration (AMD).